Vaxabov B.M. (2025). HYPERLIPIDEMIA-SPECIFIC BIOMARKERS WOULD IMPROVE CLINICAL DIAGNOSIS AND THERAPEUTIC TREATMENT AT EARLY DISEASE STAGES. Journal of Applied Science and Social Science, 15(12), 627–630. Retrieved from https://www.internationaljournal.co.in/index.php/jasass/article/view/2669